siRNA therapy decreases triglycerides in clients along with rare ailment

.ANALYSIS FEATURE.19 September 2024.

Plozasiran lessened triglyceride amounts by 80% and also lowered the risk of pancreatitis in patients with chronic chylomicronemia, along with or without a hereditary prognosis.